🇯🇵 DPT-IPV in Japan

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DPT-IPV (DPT-IPV) regulatory status in Japan.

Marketing authorisation

PMDA

Application: Tetrabik
Local brand name: Tetrabik
Status: approved

Read official source →

Other Immunology / Infectious Disease approved in Japan

Frequently asked questions

Is DPT-IPV approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for DPT-IPV in Japan?

Tanabe Pharma Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.